This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Keurig Green Mountain Slips on CFO Resignation and Weak Guidance

Shares of Keurig Green Mountain Inc (GMCR) tumbled after announcing the leave of its CFO and a weak current quarter guidance on Thursday, making it TheStreet's Move of the Day.

Michelin: Taking the Average Tire And Turning it Into a 'Tweel'

Tire maker Michelin is literally reinventing the wheel for industrial equipment and commercial mowers.

Outfront CEO Talks About Google's Giant Billboard in Times Square

CBS Outdoor is literally out the door and is now officially Outfront Media (OUT).

Toyota Working to Replace Takata Airbag Inflators Despite Tight Supplies

Toyota's U.S. Chief Bob Carter says roughly 700,000 of its cars have been affected by the Takata airbag recall.

T-Mobile Could Attract Suitors Again, Deutsche Telekom Says

Companies like Sprint and French wireless provider Iliad tried to purchase T-Mobile in recent months, but their bids were turned down.

Real Money Previews

Jim Cramer on the Stock Market: Thoughts on Foolish Groupthink

The latest example: Reams of wrongheaded hedge-fund short plays off the Ebola crisis.

Watch Out! These 'Torpedo' Stocks Could Sink Your Portfolio

It's worth paying attention to these potential portfolio killers.

Mad Money Recap

Jim Cramer's 'Mad Money' Recap: How You Can Profit From My Mistakes

Even Cramer gets them wrong once in a while and he wants you to see, and avoid, the errors of his ways.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

Must-See Charts: How to Trade IBM, Applied Materials and More

Skilled technical traders can bank gains as much as 90% of the time.

5 Stocks With Big Insider Trading: Groupon, Jive Software and More

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

5 Hated Short-Squeeze Stocks Ready to Pop: Burger King and More

Shorting in U.S. stocks is the highest it's been since September 2008. Investors hate stocks right now.

5 Under $10-Stocks Setting Up to Move Higher: Tile Shop and More

You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.

5 International Stocks to Buy for Breakout Gains This Week: Diageo and More

Primarily large-cap overseas issues that are dual-listed in the U.S. that are carving out bottoms right now.

MainStreet

Obamacare Set to Miss Enrollment Expectations: Is It Ultimately Medicaid Expanded?

A study indicates that Americans were inconvenienced and the insurance market disrupted; ultimately, the uninsured favored Medicaid.

More than Half of Americans Who Overdraft Have The Same Ailment

A GoBankingRates study reveals the reason for the typical consumer's lack of responsibility. It's time for consumer advocates to fight back.

Why Financial Advice Fails: How to Fix What Advisors and Investors Are Doing Wrong

Study says the models for success in the investment management industry are broken.

Black Friday 2014: The Best Deals from the Top Department Stores

MainStreet provides a guide to the best sales.

Brokers Gone Bad: Stealing $1 Million in Office Supplies and Defrauding Their Own Families

Do a background check on an advisor before trusting them with your money.

Biotech

Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma

The $3.3 billion paid by Royalty Pharma to the Cystic Fibrosis Foundation to acquire royalty rights to Vertex Pharmaceuticals' cystic fibrosis drugs suggests investors are under-estimating peak sales.

Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'

TheStreet's Jim Cramer says Agios Pharmaceuticals' positive Phase 1 data for its leukemia treatment is impressive. As a result, shares are going higher despite doubling since July.

Foundation Medicine Winning Increased Insurance Coverage for Genetic Cancer Tests

Coverage decisions are still likely to slowly build over time but it is a clear positive that we are seeing the early adopters start to reimburse for Foundation's cancer tests.

Beyond Wall St.

Deal News

T-Mobile Could Attract Suitors Again, Deutsche Telekom Says

Companies like Sprint and French wireless provider Iliad tried to purchase T-Mobile in recent months, but their bids were turned down.

Halliburton Buys Baker, Actavis Snares Allergan & Stanton's Big Deal

Halliburton announced it will buy fellow oil services giant Baker Hughes this week for about $35 billion in cash and stock.

Delta Awards Airbus 50-Jet Order to Renew Fleet in Snub to Boeing

Delta Air Lines has reportedly chosen Airbus for an order of 50 wide-body jets worth more than $14 billion at current list prices.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer on the Stock Market: Thoughts on Foolish Groupthink

The latest example: Reams of wrongheaded hedge-fund short plays off the Ebola crisis.

Herb Greenberg

Greenberg: How Hertz Fooled So Many Hedge Fund Managers

But suing Audit Integrity wasn't such a good idea.

Stephanie Link

Dicker/Link: Tubular Bells Offshore Project Begins Production - but No Reason Yet to Invest

Dan Dicker talks with Stephanie Link, co-portfolio director of Action Alerts, about the beginnings of production of a $2.3 billion offshore project co-owned by Hess and Chevron.

Chris Ciaccia

Gap Between iPhone 6 and 6-Plus Is Bigger Than Anyone Thought

As Apple's new iPhones show how important they are to the company, investors want to know how wide the split really is -- -- a lot wider than you think.

Adam Feuerstein

Royalty Pharma's $3.3 Billion Transaction is Bullish for Vertex Pharma

The $3.3 billion paid by Royalty Pharma to the Cystic Fibrosis Foundation to acquire royalty rights to Vertex Pharmaceuticals' cystic fibrosis drugs suggests investors are under-es...

Dan Freed

American Middle Class is 'Under Siege' Says Steve Forbes

Publisher Steve Forbes sees the potential for a bill to cut corporate taxes to pass next year.

Ted Reed

Norwegian Air CEO Touts Low Fares, Labor Calls It 'a Shell Game'

Norwegian Air CEO Bjorn Kjos says the carrier's low fares boost tourism. But ALPA President Lee Moak says Norwegian's structure is a complex 'shell game' intended to avoid labor pr...

Leon Lazaroff

Netflix Still Dominates Web Traffic Even as Amazon Keeps Growing

Netflix continues to dominate Internet traffic, accounting for one-third of all downloads during peak evening hours.

Submit an article to us!
DOW 17,719.00 +33.27 0.19%
S&P 500 2,052.75 +4.03 0.20%
NASDAQ 4,701.8670 +26.1550 0.56%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs